BioDelivery Sciences International, Inc.

Mineralys Therapeutics, Inc. , which launched the largest biopharmaceutical company initial public offering so far this year late on 9 February, was an ideal IPO candidate under current market conditi

In a proposed merger of two pain-focused specialty pharmas, Collegium Pharmaceutical, Inc. will acquire BioDelivery Sciences International, Inc. for approximately $604m, the companies announced on

The US Food and Drug Administration is facing another round of lawsuits over its marketing exclusivity decisions. Alvogen contends Teva forfeited its 180-day marketing exclusivity for a generic ve

The US Food and Drug Administration is facing another round of lawsuits over its marketing exclusivity decisions. Alvogen, Inc. contends Teva Pharmaceuticals USA Inc. forfeited its180-day marketin